Tuesday November 24 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Serono Japan Company Limited

We are one of the world’s top three biotechnology companies, with revenues of USD 1.38 billion (2001).

We currently focus on three core therapeutics areas:



Reproductive Health Multiple Sclerosis

Growth & Metabolism



We are also investing strongly in the future, as expressed by our New Therapeutic Areas.



Global reach

We operate in 45 countries and have sales in over 100 countries.


Contact Details:
Kokusai Sanno Building 9th Fl.
3-3-5 Akasaka, Minato-ku
Tokyo
107-0052
Japan
Tel:+81-3-5545-7200
Fax:+81-3-5545-7209
Email:
WWW:

www.serono.com/




BioNews Results for Serono Japan Company Limited:

Reportlinker Adds Prescription Drugs Report
PR Newswire via Yahoo!:  Sep 8 2009 2:27PM Matching: serono japan company
Reportlinker Adds Prescription Drugs Report
PR Newswire:  Sep 8 2009 2:40PM Matching: serono japan company
Reportlinker Adds Autoimmune Disease Therapeutics Report
PR Newswire:  Sep 8 2009 3:56PM Matching: serono japan company

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 378 times since April 2007, the link to the organisation's website has been followed 101 times

Recent Search Terms used to find this page: serono japan company | .

Search for more companies in 3-3-5 Akasaka, Minato-ku

Search for more companies in Tokyo



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Serono Japan Company Limited

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.